August 3rd, 2023 – Rescue Hearing Inc. (RHI) is thrilled to announce a strategic partnership with Myrtelle, a leading innovator in gene therapy solutions. This collaboration aims to accelerate the development of targeted gene therapies for hearing loss, leveraging Myrtelle’s expertise in precision medicine and RHI’s commitment to revolutionizing auditory healthcare.

Under this partnership, RHI and Myrtelle will work together to refine gene-editing techniques, optimize delivery systems, and conduct extensive research to bring effective treatments to individuals suffering from genetic hearing loss.

“This partnership is a significant step forward in our mission to eliminate hearing loss as a chronic condition,” said Jim Ayala, CEO of RHI. “By combining our expertise with Myrtelle’s cutting-edge technology, we are poised to make real progress in restoring hearing for millions worldwide.”

The collaboration will focus on preclinical studies and pave the way for future clinical trials, moving us closer to offering life-changing treatments for those affected by hearing loss.